MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 276 filers reported holding MYRIAD GENETICS INC in Q4 2014. The put-call ratio across all filers is 2.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $461,000 | +9.8% | 10,690 | -13.4% | 0.16% | +27.8% |
| Q2 2015 | $420,000 | -84.0% | 12,344 | -83.4% | 0.13% | -83.6% |
| Q1 2015 | $2,631,000 | -8.4% | 74,314 | -11.9% | 0.77% | -6.8% |
| Q4 2014 | $2,872,000 | -40.3% | 84,334 | -32.4% | 0.82% | -40.4% |
| Q3 2014 | $4,812,000 | +1.6% | 124,754 | +2.5% | 1.38% | -0.6% |
| Q2 2014 | $4,738,000 | +19.5% | 121,734 | +4.9% | 1.39% | -25.5% |
| Q1 2014 | $3,966,000 | – | 115,999 | – | 1.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |